JAKing up immunity.

Autor: Gadina M; Translational Immunology Section, Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, USA., O'Shea JJ; Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, NIAMS, NIH, Bethesda, MD, USA.
Jazyk: angličtina
Zdroj: Science (New York, N.Y.) [Science] 2024 Jun 21; Vol. 384 (6702), pp. 1303-1304. Date of Electronic Publication: 2024 Jun 20.
DOI: 10.1126/science.adq1717
Abstrakt: Janus kinase (JAK) inhibitors improve antitumor responses.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje